BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 1941617)

  • 1. Comparison of inhibitory potency by nonpeptide angiotensin II receptor antagonists PD123177 and DuP 753 on proximal nephron and renal transport.
    Cogan MG; Liu FY; Wong PC; Timmermans PB
    J Pharmacol Exp Ther; 1991 Nov; 259(2):687-91. PubMed ID: 1941617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of DuP 753 on proximal nephron and renal transport.
    Cogan MG; Xie MH; Liu FY; Wong PC; Timmermans PB
    Am J Hypertens; 1991 Apr; 4(4 Pt 2):315S-320S. PubMed ID: 1854458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proximal nephron and renal effects of DuP 753, a nonpeptide angiotensin II receptor antagonist.
    Xie MH; Liu FY; Wong PC; Timmermans PB; Cogan MG
    Kidney Int; 1990 Sep; 38(3):473-9. PubMed ID: 2232490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal hemodynamic and excretory responses to PD 123319 and losartan, nonpeptide AT1 and AT2 subtype-specific angiotensin II ligands.
    Keiser JA; Bjork FA; Hodges JC; Taylor DG
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1154-60. PubMed ID: 1527720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2).
    Wong PC; Hart SD; Zaspel AM; Chiu AT; Ardecky RJ; Smith RD; Timmermans PB
    J Pharmacol Exp Ther; 1990 Nov; 255(2):584-92. PubMed ID: 2243344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DuP 753 can antagonize the effects of angiotensin II in rat liver.
    Bauer PH; Chiu AT; Garrison JC
    Mol Pharmacol; 1991 Apr; 39(4):579-85. PubMed ID: 2017158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of angiotensin II binding affinity by allosteric interaction of polyvinyl sulfate with an intracellular domain of the DuP-753-sensitive angiotensin II receptor of bovine adrenal glomerulosa.
    Boulay G; Servant G; Luong TT; Escher E; Guillemette G
    Mol Pharmacol; 1992 Apr; 41(4):809-15. PubMed ID: 1569928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of angiotensin II in dietary modulation of rat late distal tubule bicarbonate flux in vivo.
    Levine DZ; Iacovitti M; Buckman S; Burns KD
    J Clin Invest; 1996 Jan; 97(1):120-5. PubMed ID: 8550822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of glomerular angiotensin II receptor subtypes.
    Gauquelin G; Garcia R
    Receptor; 1992; 2(3):207-12. PubMed ID: 1472951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the specific angiotensin II receptor antagonist losartan on urate homeostasis and intestinal urate transport.
    Hatch M; Freel RW; Shahinfar S; Vaziri ND
    J Pharmacol Exp Ther; 1996 Jan; 276(1):187-93. PubMed ID: 8558429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective antagonism of the AT1 receptor inhibits the effect of angiotensin II on DNA and protein synthesis of rat proximal tubular cells.
    Weerackody RP; Chatterjee PK; Mistry SK; McLaren J; Hawksworth GM; McLay JS
    Exp Nephrol; 1997; 5(3):253-62. PubMed ID: 9208286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II-1 receptors mediate both vasoconstrictor and hypertrophic responses in rat aortic smooth muscle cells.
    Chiu AT; Roscoe WA; McCall DE; Timmermans PB
    Receptor; 1991; 1(3):133-40. PubMed ID: 1843203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtype 2 of angiotensin II receptors controls pressure-natriuresis in rats.
    Lo M; Liu KL; Lantelme P; Sassard J
    J Clin Invest; 1995 Mar; 95(3):1394-7. PubMed ID: 7883985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interference with feedback control of glomerular filtration rate by furosemide, triflocin, and cyanide.
    Wright FS; Schnermann J
    J Clin Invest; 1974 Jun; 53(6):1695-708. PubMed ID: 4830232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of angiotensin II receptor subtypes in the rat kidney and heart using the non-peptide antagonists DuP 753 and PD 123 177.
    Sechi LA; Grady EF; Griffin CA; Kalinyak JE; Schambelan M
    J Hypertens Suppl; 1991 Dec; 9(6):S224-5. PubMed ID: 1818953
    [No Abstract]   [Full Text] [Related]  

  • 16. DuP 532, an angiotensin II receptor antagonist: first administration and comparison with losartan.
    Goldberg MR; Lo MW; Christ DD; Chiou R; Furtek CI; Amit O; Carides A; Biollaz J; Piguet V; Nussberger J; Brunner HR
    Clin Pharmacol Ther; 1997 Jan; 61(1):59-69. PubMed ID: 9024174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of losartan (DuP 753)-induced angiotensin II receptor antagonism by PD123177 in rats.
    Wong PC; Christ DD; Timmermans PB
    Eur J Pharmacol; 1992 Sep; 220(2-3):267-70. PubMed ID: 1425998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of angiotensin on proximal tubular reabsorption.
    Schuster VL
    Fed Proc; 1986 Apr; 45(5):1444-7. PubMed ID: 3514281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the angiotensin antagonist DuP 753 on the renal adaptation to sodium restriction in the rat.
    Jover B; Dupont M; Nafrialdi E; Mimran A
    J Hypertens Suppl; 1991 Dec; 9(6):S210-1. PubMed ID: 1818949
    [No Abstract]   [Full Text] [Related]  

  • 20. [Angiotensin receptors in the rat myocardium during pre- and postnatal development].
    Sechi LA; Sechi G; De Carli S; Griffin CA; Schambelan M; Bartoli E
    Cardiologia; 1993 Jul; 38(7):471-6. PubMed ID: 8221742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.